Found 4 results

↓ CSV
Name Type of Offering Accepted Date
Equilibre BioPharmaceuticals Corp. See All Filings
D 2020-11-12 12:10:33
Amount To Be Raised $35,799,973
Associated Brokers / Dealers N/A
CIK Number 0001831900
Filed Document 0001831900-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-11-12 12:10:33
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Equilibre BioPharmaceuticals Corp. See All Filings
D/A 2022-12-01 14:30:25
Amount To Be Raised $6,000,002
Associated Brokers / Dealers N/A
CIK Number 0001831900
Filed Document 0001831900-22-000002
Exclusions or Exemptions 506b
Accepted Date 2022-12-01 14:30:25
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Equilibre BioPharmaceuticals Corp. See All Filings
D 2022-11-30 21:31:34
Amount To Be Raised $6,000,002
Associated Brokers / Dealers N/A
CIK Number 0001831900
Filed Document 0001831900-22-000001
Exclusions or Exemptions 506b
Accepted Date 2022-11-30 21:31:34
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Equilibre BioPharmaceuticals Corp. See All Filings
D 2022-01-20 14:25:36
Amount To Be Raised $25,000,000
Associated Brokers / Dealers N/A
CIK Number 0001831900
Filed Document 0000947871-22-000085
Exclusions or Exemptions 506b
Accepted Date 2022-01-20 14:25:36
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity